- Author:
Myung Woo CHOI
1
;
Sung Sik OH
;
Mi Rim CHOI
;
Jong Hwa LEE
;
Hyun Ju YANG
;
In O SUN
;
Kwang Young LEE
Author Information
- Publication Type:Case Report
- Keywords: Chryseobacterium indologenes; Peritonitis; Peritoneal dialysis; Continuous ambulatory; Catheters; Indwelling
- MeSH: Bacillus; Catheters; Chryseobacterium; Ciprofloxacin; Humans; Incidence; Korea; Levofloxacin; Peritoneal Dialysis; Peritonitis; Trimethoprim, Sulfamethoxazole Drug Combination
- From:Korean Journal of Medicine 2018;93(1):65-67
- CountryRepublic of Korea
- Language:English
- Abstract: Chryseobacterium indologenes (C. indologenes) is a nonmotile, gram-negative bacillus that is widely distributed in nature. Generally considered nonpathogenic, C. indologenes rarely infects humans and is not normally present in the human microflora. C. indologenes infections have been observed in cases of peritoneal dialysis (PD)-associated peritonitis, although the incidence of these infections is low. Although C. indologenes is generally susceptible to trimethoprim-sulfamethoxazole, levofloxacin, ciprofloxacin, piperacillin-tazobactam, and cefepime, no guidelines have been established for the treatment of PD-associated peritonitis. Here we report the first case of PD-associated peritonitis in Korea with C. indologenes identified as the sole etiologic agent. The patient recovered after intraperitoneal antibiotic treatment without the need for Tenckhoff catheter removal.